A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential T...

by Spyros Papapetropoulos, Margaret S. Lee, Stacey Boyer, Evan J. Newbold
Published 2019-06-01

Biometric Digital Health Technology for Measuring Motor Function in Parkinson’s Disease: Results from a Feasibility and Patient Satisfaction Study

by Georgia Mitsi, Enrique Urrea Mendoza, Benjamin D. Wissel, Elena Barbopoulou, Elena Barbopoulou, Alok K. Dwivedi, Ioannis Tsoulos, Athanassios Stavrakoudis, Alberto J. Espay, Spyros Papapetropoulos
Published 2017-06-01

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

by Shani Cohen, Zeev Waks, Jordan J. Elm, Mark Forrest Gordon, Igor D. Grachev, Leehee Navon-Perry, Shai Fine, Iris Grossman, Spyros Papapetropoulos, Juha-Matti Savola
Published 2018-12-01